TR200401671T1 - Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi - Google Patents

Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi

Info

Publication number
TR200401671T1
TR200401671T1 TR2004/01671T TR200401671T TR200401671T1 TR 200401671 T1 TR200401671 T1 TR 200401671T1 TR 2004/01671 T TR2004/01671 T TR 2004/01671T TR 200401671 T TR200401671 T TR 200401671T TR 200401671 T1 TR200401671 T1 TR 200401671T1
Authority
TR
Turkey
Prior art keywords
eliminating
formula
sulfone
synthesis
compounds
Prior art date
Application number
TR2004/01671T
Other languages
English (en)
Inventor
Ünsal Şerafetti̇n
Original Assignee
Ulkar Ki̇mya Sanayi̇i̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulkar Ki̇mya Sanayi̇i̇ Ve Ti̇caret A.Ş. filed Critical Ulkar Ki̇mya Sanayi̇i̇ Ve Ti̇caret A.Ş.
Publication of TR200401671T1 publication Critical patent/TR200401671T1/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMUL I Omeprazol,lansoprazol ve pantoprazol gibi Formül-1 de yapisi verilen piridinbenzimidazol sülfinil bilesiklerinin üretim prosesidir. Kimyasal yapida A halkasi opsiyonel olarak sübstitüe edilebilen bir gruptur; R1 hidrojen veya azotu koruyan bir gruptur, R2,R3,R4 ten herbiri 1) hidrojen atomu 2) gerektiginde halojen atomu veya atomlari ile sübstitüe edilebilen bir alkil grubu veya 3)halojen atomu veya atomlari veya alkoksi grubu ile sübstitüe edilebilen bir alkoksi grubu olup ayrica tuzlarini ihtiva eder. Genel yapisi formül 1 de verilen bu bilesikler, karsiliklari olan sülfitlerin oksidasyonu ile elde edilirken reaksiyon sirasinda sülfoksit ile birlikte bir yan ürün olarak sülfon olusur. Bu bulus, olusan sülfon impüritelerinin bilesikten elimine edilmesi metodunu içermektedir. Bu söz konusu saflastirma metodu, yari saf haldeki ürününün alkol ortaminda yüksek derecelerde çözünüp kati halde K2CO3 kristalleri ile muamele edilmesine dayanir.
TR2004/01671T 2002-01-23 2002-10-01 Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi TR200401671T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR200200186 2002-01-23
PCT/TR2002/000058 WO2003062223A1 (en) 2002-01-23 2002-10-01 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides

Publications (1)

Publication Number Publication Date
TR200401671T1 true TR200401671T1 (tr) 2005-04-21

Family

ID=27607405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01671T TR200401671T1 (tr) 2002-01-23 2002-10-01 Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi

Country Status (4)

Country Link
EP (1) EP1476441B1 (tr)
DE (1) DE60220448T2 (tr)
TR (1) TR200401671T1 (tr)
WO (1) WO2003062223A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510849A1 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
WO2004111029A2 (en) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
EP1716136A1 (en) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.
ES2294931B1 (es) * 2006-06-29 2008-12-16 Quimica Sintetica, S.A. Sal de l-arginina de esomeprazol, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
JP2010519284A (ja) * 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245913B1 (en) * 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole

Also Published As

Publication number Publication date
WO2003062223A1 (en) 2003-07-31
DE60220448D1 (de) 2007-07-12
EP1476441A1 (en) 2004-11-17
EP1476441B1 (en) 2007-05-30
DE60220448T2 (de) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20066015L (no) Fuserte heterosykliske forbindelser
NO20075768L (no) Hydroksybenzamidderivater og deres anvendelse som inhibitorer av HSP90
CY1113099T1 (el) Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2
CA2631880A1 (en) Chromane substituted benzimidazoles and their use as acid pump inhibitors
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
NO20041580L (no) Pyrimidinforbindelse og medisinsk preparat derav
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
HUP0400610A2 (hu) Javított eljárás benzimidazoltípusú vegyületek előállítására
TN2010000053A1 (fr) Derives de bi cyclolactames substitues
NO20083520L (no) Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser
CY1114927T1 (el) Νεα 2-υποκατεστημενα παραγωγα μεθυλο πεναμης
RU2010125902A (ru) Способ получения замещенных гетероциклом производных пиридина
DK1113011T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
WO2009010789A3 (en) Pyrimidine derivatives 934
AR042179A1 (es) Derivados de pirimidin-2 ona, procedimiento para sintetizarlos, una composicion, un procedimiento para la preparacion de la composicion y el uso de dichos compuestos para medicamentos
TR200401671T1 (tr) Piridin benzimidazol sülfinil bileşiklerinin sentesi sırasında oluşan sulfon analoglarının elimine edilmesi yöntemi
NO20024858D0 (no) Fremgangsmåte for fremstilling av derivater av [[(substituert pyridyl)metyl]tio]benzimidazol
HUP0303144A2 (hu) Eljárások szubsztituált 2-(2-piridil-metil)-szulfinil-1H-benzimidazolok előállítására
MXPA06002767A (es) 2-carbonilamino-6-piperidinaminopiridinas substituidas y 1-carbonilamino-3-piperidinaminobenzenos y sustituidos como agonistas de 5-ht1f.
NO20065681L (no) 4-fenyl-1-piperazinyl, -piperidinyl og -tetrahydropyridylderivater
DK1487818T3 (da) Alkylammoniumsalte af omeprazol og esomeprazol
MA32976B1 (fr) Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif
DE69521687D1 (de) 4-indol-1-yl-buttersäure derivate, deren herstellung und deren verwendung als inhibitoren für alpha1-adrenerge rezeptoren und testosteron 5alpha-reduktasen
JP2008540333A5 (tr)
GB0215392D0 (en) Chemical compounds